The Johnson & Johnson vaccine should be considered a two-dose vaccine rather than a one-shot that received initial approval, a federal panel ruled Friday.
The committee felt that the 15 million Americans who received a single dose of the “one and done” J&J vaccine would be well protected enough with the second.
The unanimous decision of the Vaccine and Related Organic Products Advisory Committee came after real-world data showed that J&J’s one-shot vaccine was not as effective in real-world research as the Pfizer and modern vaccines.
“Because the dosage is lower than what was seen with the mRNA vaccine – the same with the mRNA vaccine – there is headroom to improve efficacy,” said Dr. Penny Heaton, head of the vaccine global therapeutic area at Janssen Pharmaceuticals. , A Johnson & Johnson company that developed the vaccine.
Heaton told the committee Friday that adding a second dose 2 to 6 months after the initial J&J shot would provide the same effectiveness as the mRNA vaccine.
The committee convened Friday to discuss whether the second dose of the Johnson & Johnson Covid-1 vaccine should be supported, at least two months after the initial dose of each of those who received the initial shot of the vaccine.
The panel on Thursday edited to support booster shots of the Modern Covid-1 vaccine for people aged 5 and over, as well as certain medical conditions or jobs in young adults that increase their risk of infection. The booster will be half the regular dose, at least six months after the second shot.
Pfizer-BioNTech’s booster currently recommends for approved panel moderns for the same risk group.
– Elizabeth Weiss and Karen Weintrab
Also in the news:
– The United States will allow vaccinated foreign nationals to enter the country from November inated under a new international travel system. Foreign national air travelers must be vaccinated and provide proof of immunization in order to travel to the United States and show a pre-departure negative test within three days of travel prior to boarding.
Pennsylvania became the seventh state to report 1.5 million coronavirus cases on Friday. Most states include California, about 8. million; Texas, about 4.2 million; And Florida, more than 3.6 million.
Rit British health officials said an estimated 43,000 people in England on Friday may have received false-negative COVID-19 test results due to problems in a private laboratory.
– Strict vaccine requirements for all Italian workers have been in effect since Friday. This rule requires all employees to show a health pass to enter their place of employment. Police were enforceable because the protests were expected against the rules and could take violent forms.
More than 100 workers at the Los Los Alamos National Laboratory, the nuclear lab where the atomic bomb was made, are suing for a vaccine mandate that gives them until Friday to be vaccinated or expelled.
The office of Inn Finnish President Sauli Ninstore says he is isolating himself as a precaution after coming in contact with the coronavirus after a meeting with a Latvian colleague in Sweden.
Anyone aged 12 or older must provide proof of COVID-19 vaccine or recent negative test to participate in a major event in Washington state from November 15.
📈 Today’s numbers are numbers According to Johns Hopkins University data, more than 44.7 million confirmed Covid-19 cases and more than 721,500 deaths have been recorded in the United States. Worldwide total: more than 239.7 million cases and 4.8 million deaths. According to the CDC, more than 188.2 million Americans – 56.7% of the population – have been fully vaccinated.
What we read: During the epidemic, some college football coaches cashed in despite coward-related cutbacks. Brian Goff, a professor of economics at Western Kentucky, said doing so has created a “misleading” discrepancy between “spending as usual” and “weak talk and penny-pitching” since the epidemic began.
Keep refreshing this page for the latest news. Want more? Sign up for USA TODAY’s Coronavirus Watch newsletter to receive updates directly in your inbox and join our Facebook group.
The Covid-1 vaccine did not work, the new study said
A study published Friday in the Journal of the American Medical Association found that the announcement of a large cash lottery did not improve vaccines for those who received their COVID-19 vaccine.
To get the vaccine, 1 state has announced a big cash lottery by July 1, according to the authors, who are economists at various universities in the United States. The authors found that there was “no statistically significant relationship” between the announcement and the number of ticks before or after the announcement date.
“Lottery-style drawings may be less effective than incentives that are definitely provided,” the authors wrote. “Another possibility is that the drawings were not an informative vaccine promotional strategy and a more complete message about the vaccine would have been much more effective.”
A study in July reached a similar conclusion. Researchers at the Boston University School of Medicine found in that report that Ohio’s lottery ticker rates did not increase compared to states other than lottery-based incentive methods. However, several subsequent independent analyzes have found that Wax-a-million gifts in Ohio have contributed to more people being vaccinated in the state.
– Grace Hawk
CDC data shows how good vaccination is
Newly published Centers for Disease Control and Prevention shows how people of all ages and the three vaccine brands used in the United States have been much better off than the Covid-1 infections and non-communicable diseases.
In August, vaccinated people are more likely to die of Covid-1 of 11. times multiplied and the probability of positive testing .1.1 times higher, shows real world data.
The worst reported deaths per week around 8 August were, for example, 13.23 deaths per 100,000 vaccinated people, compared to Johnson & Johnson recipients at 3.14, Pfizer at 1.43 and Modern at 0.73.
Vaccines do not dramatically alter the outcome of the Covid-1 outcome for adults. People who are 80 years of age or older who are fully vaccinated are slightly less likely to die from the disease than those who were not vaccinated in their 50s or early sixties. People of all ages are less likely to be vaccinated positive than people of any age who have not been vaccinated.
The CDC says the data came from one government, which represents about 100 percent of New York City’s population, from Florida to Wisconsin to Utah.
– Mike Stuka
These vaccinated travelers want to go to the United States. They may not be allowed.
Earlier this year when India saw a massive increase in Covid-1 sur, Jayaram Tadimeti was happy to get the vaccine as soon as possible. Now, this is a decision he is partially saddened by.
The 32-year-old received two doses of the popular covacin vaccine in India in May and June, the COVID-19 vaccine being popular. She worries that her choice of vaccine will prevent her from meeting friends and family in the United States when the country allows international visitors to enter next month. Only foreign nationals who have been fully vaccinated by the U.S. Food and Drug Administration or approved by the World Health Organization can enter the country. As of Thursday, Kovacin is not on that list.
The decision by U.S. officials to reconsider the country’s entry requirements was welcome news for many travelers, but those who have received the vaccine and who have not received WHO approval stamps are wondering when they will have the opportunity to reconnect with loved ones in the state. .
Tadimeti recently moved to Toronto and bought a plane ticket to attend a friend’s wedding in Texas over the Thanksgiving weekend, but he’s not sure he’ll be able to attend. Read more here.
– Bailey Schulz
The FDA will call an independent panel on Mark’s Covid pill
The Food and Drug Administration said Thursday it will call in a panel of outside experts next month to review information on the safety and efficacy of Mark’s pill for the treatment of Covid-1 treat.
Although those panels were standard for reviewing vaccine data, the FDA has not yet formed a similar panel for the treatment of Covid-1 treatments.
“We believe that, in this case, a public discussion of this information with the agency’s advisory committee will help ensure a clear understanding of scientific data and information,” said Dr. Pat Patrizia Kavajoni, director of the FDA’s drug center.
The group will meet on November 30, which means Merck’s pills will probably not be approved until December.
Earlier this month, Mark said its test data showed the test drug had prevented half of the deadly coronavirus infections that would otherwise have sent people to the hospital.
‘Break up’ with J&J? Some are ready to use Pfizer or Modern
As an FDA panel considers Johnson & Johnson booster shots on Friday, a day after supporting low-dose modern booster, some recipients of the first J&J shots say they don’t necessarily want another dose of the company’s vaccine.
Jill Oliver, 56, a resident of Boulder, Colorado, said: “I’m going to sever ties with J&J. He was hesitant to get a company shot in March. Although he wanted to wait for a modern or Pfizer vaccine, he listened to public health leaders The first vaccine is available.
“I thought I was doing the right thing,” Oliver said. “Now, I’m walking around with my mask on and not feeling safe when I got on the plate and did what I was told.”
Studies have shown that while it remains highly effective in preventing serious illness and death, the J&J vaccine is less effective in preventing significant COVID infections than modern and Pfizer. And data from J&J boosters remains limited.
– Adriana Rodriguez
Florida Governor vows to challenge Biden’s Covid vaccine mandate
Florida will challenge the Biden administration’s vaccine mandate in federal court, Governor Ron de Santis said Thursday, requiring businesses and hospitals to stay pending “reduced.”
President Joe Biden’s order has not yet been released but is expected later this month. This applies to hospitals that treat Medicare and Medicaid patients and employers with 100 or more employees.
Some Florida hospitals already require the COVID-19 vaccine in anticipation of the upcoming federal administration.
“We’re going to compete with it immediately,” De Santis said Thursday at a Florida Department of Health office, where he linked the promotion of his monochromatic antibody treatment to recent statewide Covid hospital admissions. “And I think we’re going to lose the mandate in court. I also think we have a responsibility at the state level to do what we have to do to protect Floridians from the mandate so they can lose their jobs.”
Dissent, who has been adamant in his opposition to the vaccine requirement, cites unconfirmed statistics from monoclonal treatment centers, noting that a large percentage of those seeking treatment have already been vaccinated. USA Today Network – Florida filed a public record request more than a week ago for these figures. The Florida Department of Health did not create these.
-Frank Gluck, Fort Myers News-Press
Modern Booster is supported by the Advisory Panel for the Elderly, Risky
A federal advisory committee unanimously supports booster shots of the Modern Covid-1 vaccine for people 5 years of age or older, as well as certain medical conditions or jobs in young adults that increase their risk of infection. The booster will be half the regular dose, at least six months after the second shot.
If the panel’s decision is verified by a second advisory group and top officials from the Food and Administration Administration, the Modern Booster will be the second to be approved for emergency use. Pfizer-BioNTech additional shots were approved late last month.
– Karen Weintrab and Elizabeth Weiss, USA Today
Contributed by: Associated Press